The KEYNOTE-061 trial

Lancet. 2019 Mar 16;393(10176):1098. doi: 10.1016/S0140-6736(18)33073-3. Epub 2019 Mar 14.

Author

Fei Liang¹

Affiliation

¹ Clinical Statistics Center, Shanghai Cancer Center, Fudan University, 20003, Shanghai, China. Electronic address: liangfei0726@163.com.

PMID: 30894265
DOI: 10.1016/S0140-6736(18)33073-3

No abstract available

Publication types

Letter
Comment

MeSH terms

Antibodies, Monoclonal, Humanized
Esophagogastric Junction
Humans
Neoplasms*
Paclitaxel*

Substances

Antibodies, Monoclonal, Humanized
pembrolizumab
Paclitaxel